The image shows the compound Tat-P4-(C5)2 after an injection into the spinal cord. The compound (purple) penetrates the nerve cells of the spinal cord (yellow), but not the surrounding cells (the cell nuclei are blue). Credit: University of Copenhagen.
Researchers from the University of Copenhagen have developed a new way to treat chronic pain which has been tested in mice. With a compound designed and developed by the researchers themselves, they can achieve complete pain relief.
Between seven and ten percent of the world’s population suffers from chronic pain originating from nerves that have been damaged. A disease that can be severely debilitating. Now, researchers from the University of Copenhagen have found a new way to treat the pain.
The treatment has been tested in mice, and the new results have been published in the scientific journal EMBO Molecular Medicine. For more than a decade, the researchers have been working to design, develop and test a drug that shall provide complete pain relief.
“We have developed a new way to treat chronic pain. It is a targeted treatment. That is, it does not affect the general neuronal signalling, but only affects the nerve changes that are caused by the disease,” says co-author Kenneth Lindegaard Madsen, Associate Professor at the Department of Neuroscience, University of Copenhagen.
“We have been working on this for more than ten years. We have taken the process all the way from understanding the biology, inventing and designing the compound to describing how it works in animals, affects their behaviour and removes the pain,” says Kenneth Lindegaard Madsen.
Chronic pain can occur, among other things, after surgery, in people with diabetes, after a blood clot and after an amputation in the form of phantom pain.
Clinical trials as the next step
The compound developed by the researchers is a so-called peptide named Tat-P4-(C5)2. The peptide is targeted and only affects the nerve changes that pose a problem and cause the pain.
In a previous study, the researchers have shown in an animal model that use of the peptide can also reduce addiction. Therefore, the researchers hope that the compound may potentially help pain patients who have become addicted to, for example, opioid pain relievers in particular.
“The compound works very efficiently, and we do not see any side effects. We can administer this peptide and obtain complete pain relief in the mouse model we have used, without the lethargic effect that characterises existing pain-relieving drugs,” says Kenneth Lindegaard Madsen, adding:
“Now, our next step is to work towards testing the treatment on people. The goal, for us, is to develop a drug, therefore the plan is to establish a biotech company as soon as possible so we can focus on this.”
The researchers are now working towards clinical trials in collaboration with, among others, pain researcher Nanna Brix Finnerup, Professor at Aarhus University.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Researchers chronicle sex differences in origin of chronic pain at cellular levelon November 12, 2020 at 6:16 am
Scientists in The University of Texas at Dallas' Center for Advanced Pain Studies (CAPS) have furthered the understanding of how chronic pain functions differently in males and females, including ...
- Mindfulness-Based Stress Reduction Alleviates Chronic Pain and Depression, According to New Studyon November 11, 2020 at 12:02 pm
This time-tested eight-week yoga and meditation program reduced symptoms of chronic pain, offering an alternative to opioid medication.
- Why You May Have Hip Pain When You’re Sittingon November 10, 2020 at 12:31 pm
You might have hip pain when sitting just once or twice, or it may be chronic. In most cases, hip pain when sitting can be solved by improving your posture or changing where you’re sitting.
- Abbott begins U.S. rollout of its radiofrequency ablation device for chronic painon November 10, 2020 at 11:45 am
Abbott has begun the U.S. launch of its first company-developed radiofrequency ablation system, designed to target and burn out specific nerves with heat energy to prevent pain signals from reaching ...
- Psychology Todayon November 10, 2020 at 9:32 am
Chronic pain is a condition in the nervous system where a light switch got turned on and never got turned off. Patients initially experience pain because of some type of injury that has occurred ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- New Unemployment Claims Dip, but Economic Pain Persistson November 12, 2020 at 5:17 pm
New claims for benefits continued to flood state unemployment offices last week as the coronavirus pandemic inflicted further economic damage. Initial claims declined to a new low from the ...
- DNA ‘super-enhancers’ offer target for endometriosis treatmenton November 12, 2020 at 2:02 pm
Discovery of a potential genetic target may lead to better treatments for women who suffer from an especially painful and invasive form of endometriosis.
- Bioventus to Provide CVS Caremark® with its Portfolio of Preferred Options for Knee Osteoarthritis Patients Seeking Pain Reliefon November 10, 2020 at 7:01 am
Bioventus, a global leader in Innovations For Active Healing, will gain preferred access through the CVS Caremark Formulary, to DUROLANE®, GELSYN-3® and SUPARTZ FX®, for the treatment of knee ...
- Mind Body Matrix Pain Cream Reviews – Does This Pain Relief Cream Really Works?on November 7, 2020 at 12:03 am
You have to have control over your body and mind to manage your pain effectively. Mind-Body Matrixis a natural blend of several fine plant extracts and potent essential oils to provide you relief from ...
- Best CBD Oil For Pain Relief: 7 Top Rated CBD Oil Product Reviews 2020on November 6, 2020 at 10:09 am